FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

3186711000001102: Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25748901000001113 Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
67059101000001112 Zelapar 1.25mg oral lyophilisates (Teva UK Ltd) 30 tablet 3 x 10 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Is a Selegiline 1.25mg oral lyophilisates sugar free 30 tablet true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Is pack of Zelapar 1.25mg oral lyophilisates (Medeus Pharma) false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has active ingredient Selegiline hydrochloride false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has excipient Aspartame false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has AMP Zelapar 1.25mg oral lyophilisates (Medeus Pharma) true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has specific active ingredient Selegiline hydrochloride true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Has dispensed dose form Conventional release oral lyophilisate true Inferred relationship Existential restriction modifier
Zelapar 1.25mg oral lyophilisates (Medeus Pharma) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start